Actuate Therapeutics Files 8-K

Ticker: ACTU · Form: 8-K · Filed: May 6, 2025 · CIK: 1652935

Actuate Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyActuate Therapeutics, Inc. (ACTU)
Form Type8-K
Filed DateMay 6, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, corporate-filing, routine-report

TL;DR

Actuate Therapeutics filed a routine 8-K. No major news.

AI Summary

Actuate Therapeutics, Inc. filed an 8-K on May 6, 2025, reporting other events and financial statements. The company, formerly known as Apotheca Therapeutics, Inc. until September 11, 2015, is incorporated in Delaware and headquartered in Fort Worth, Texas. The filing does not disclose specific financial figures or material events beyond its routine reporting nature.

Why It Matters

This 8-K filing indicates routine corporate reporting by Actuate Therapeutics, Inc. It does not contain information about significant new developments, acquisitions, or financial performance.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for other events and financial statements, with no disclosed material changes or significant financial information.

Key Players & Entities

  • Actuate Therapeutics, Inc. (company) — Registrant
  • Apotheca Therapeutics, Inc. (company) — Former company name
  • May 6, 2025 (date) — Date of report
  • Delaware (jurisdiction) — State of incorporation
  • Fort Worth, Texas (location) — Principal executive offices

FAQ

What is the primary purpose of this 8-K filing for Actuate Therapeutics, Inc.?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of May 6, 2025.

When did Actuate Therapeutics, Inc. change its name from Apotheca Therapeutics, Inc.?

Actuate Therapeutics, Inc. changed its name from Apotheca Therapeutics, Inc. on September 11, 2015.

In which state is Actuate Therapeutics, Inc. incorporated?

Actuate Therapeutics, Inc. is incorporated in Delaware.

What is the business address of Actuate Therapeutics, Inc.?

The business address of Actuate Therapeutics, Inc. is 1751 River Run, Suite 400, Fort Worth, Texas 76107.

Does this filing disclose any specific new material events or financial results?

No, this filing is categorized under 'Other Events' and 'Financial Statements and Exhibits' and does not specify any new material events or detailed financial results within the provided text.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding ACTUATE THERAPEUTICS, INC. (ACTU).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.